Tellus BioVentures logo

Tellus BioVentures

North America, New York, United States, Florida

Description

Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation.

Investor Profile

Tellus BioVentures has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.

Stage Focus

  • Seed (33%)
  • Series A (33%)
  • Series Unknown (17%)
  • Series B (8%)
  • Post Ipo Equity (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Medical
  • Bioinformatics
  • Test And Measurement
  • Pharmaceutical
  • Life Science
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tellus BioVentures frequently co-invest with?

The Mark Foundation for Cancer Research
North America, New York, United States, New York
Co-Investments: 2
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Fairmount Funds Management
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 5
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 3
University of Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2

Which angels does Tellus BioVentures often collaborate with?

BA
North America, Maryland, United States, Baltimore
Shared Deals: 1

What are some of recent deals done by Tellus BioVentures?

Dianthus Therapeutics

Waltham, Massachusetts, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityJan 22, 2024
Amount Raised: $230,000,000
Cantai Therapeutics

Philadelphia, Pennsylvania, United States

Cantai Therapeutics operates as a developer of drug candidates.

Life ScienceMedical
SeedNov 20, 2023
Amount Raised: $700,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
Series UnknownNov 14, 2023
Amount Raised: $15,000,000
Praeventix

Exton, Pennsylvania, United States

Praeventix is a biotechnology company developing therapeutics to treat bowel diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownNov 8, 2022
Amount Raised: $4,320,446
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series BNov 7, 2022
Amount Raised: $118,000,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
SeedJun 7, 2022
Amount Raised: $10,000,000
Dianthus Therapeutics

Waltham, Massachusetts, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

BiopharmaBiotechnologyHealth Care
Series AApr 19, 2022
Amount Raised: $100,000,000
Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AMay 18, 2021
Amount Raised: $76,000,000
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series AMar 23, 2021
TamuroBio

Mclean, Virginia, United States

TamuroBio is an operator of a biotechnology company intended to develop novel therapeutics for NAFLD/NASH and Type 2 diabetes.

Biotechnology
SeedJan 1, 2021

Find More Investors Like Tellus BioVentures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Tellus BioVentures | Pipeseed